Katherine A. Riccione

Author

Duke University

Also Known As

K. Riccione, K.A. Riccione, Katherine A Riccione, Katherine A. Riccione, Katherine Riccione

Publications

503

Citations

H-Index

Concepts

All Affiliations

Duke University Duke Medical Center Duke University Hospital Center for Systems Biology

About

Katherine A. Riccione is an author at Duke University specializing in radiation oncology, immunotherapy, and neuro-oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	31
2	Natural Sciences	1	1	76
3	Biology	1	1	76
4	Cell Biology	1	1	17
5	Cellular Therapies	1	1	17

Katherine A. Riccione

Publications

444

Citations

H-Index

Page 1

	Year	Citations
The inoculum effect and band‐pass bacterial response to periodic antibiotic treatment Cheemeng Tan, Robert P. Smith, Jaydeep K. Srimani, Molecular Systems Biology	2012	105
Dendritic Cells Enhance Polyfunctionality of Adoptively Transferred T Cells That Target Cytomegalovirus in Glioblastoma Elizabeth A. Reap, Carter M. Suryadevara, Kristen A. Batich, Cancer Research	2017	105
Temozolomide lymphodepletion enhances CAR abundance and correlates with antitumor efficacy against established glioblastoma Carter M. Suryadevara, Rupen Desai, Melissa L. Abel, OncoImmunology	2018	100
Programmed Allee effect in bacteria causes a tradeoff between population spread and survival Robert P. Smith, Cheemeng Tan, Jaydeep K. Srimani, Proceedings of the National Academy of Sciences BiologyEngineered BacteriaTheoretical EcologyPathogen TransmissionPopulation Spread	2014	76
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care Katherine A. Riccione, Carter M. Suryadevara, David J. Snyder, Journal of Visualized Experiments Cell TherapyImmunologyHigh-grade GliomasImmune Cell TherapyImmunotherapy	2015	17
CD27 stimulation unveils the efficacy of linked class I/II peptide vaccines in poorly immunogenic tumors by orchestrating a coordinated CD4/CD8 T cell response Katherine A. Riccione, Li-Zhen He, Peter E. Fecci, OncoImmunology	2018	15
Immunotherapy Gone Viral: Bortezomib and oHSV Enhance Antitumor NK-Cell Activity Carter M. Suryadevara, Katherine A. Riccione, John H. Sampson Clinical Cancer Research Proteasome InhibitorsImmunologyImmunoeditingCell DeathPathology	2016	14
A conjoined universal helper epitope can unveil antitumor effects of a neoantigen vaccine targeting an MHC class I-restricted neoepitope Adam M. Swartz, Kendra L. Congdon, Smita K. Nair, npj Vaccines	2021	12

Page 1